Humana Inc. (NYSE: HUM) Stock Competitors & Peer Comparison
See HUM's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for HUM and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HUM | $387.09 | +0.36% | 44.8B | 23.52 | $15.86 | +0.94% |
| UNH | $404.47 | -1.04% | 365.3B | 24.61 | $16.34 | +2.22% |
| CVS | $94.24 | -1.49% | 119.3B | 11.93 | $7.84 | +2.85% |
| ANTM | $482.58 | +2.71% | 114.6B | 18.99 | $25.41 | +1.42% |
| ELV | $395.25 | -0.62% | 84.7B | 13.28 | $29.39 | +1.76% |
| CI | $276.00 | -0.86% | 72.4B | 8.86 | $30.90 | +2.26% |
| CNC | $66.62 | +0.08% | 32B | 25.74 | $2.52 | N/A |
| MOH | $202.71 | +1.95% | 10.2B | 28.10 | $6.92 | N/A |
| OSCR | $28.83 | +4.19% | 7.2B | 19.97 | $1.40 | N/A |
| ALHC | $13.59 | -1.39% | 2.7B | 146.67 | $0.09 | N/A |
Stock Comparison
UnitedHealth Group Incorporated (NYSE: UNH)
HUM vs UNH Comparison August 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 44.8B. In comparison, UNH has a market cap of 365.3B. Regarding current trading prices, HUM is priced at $387.09 on the NYSE, while UNH trades at $404.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 23.52, whereas UNH's P/E ratio is 24.61. In terms of profitability, HUM's ROE is +0.07%, compared to UNH's ROE of +0.14%. Regarding short-term risk, HUM is more volatile compared to UNH. This indicates higher risk in terms of short-term price fluctuations for HUM.Check UNH's competition here
CVS Health Corp. (NYSE: CVS)
HUM vs CVS Comparison August 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 44.8B. In comparison, CVS has a market cap of 119.3B. Regarding current trading prices, HUM is priced at $387.09 on the NYSE, while CVS trades at $94.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 23.52, whereas CVS's P/E ratio is 11.93. In terms of profitability, HUM's ROE is +0.07%, compared to CVS's ROE of +0.06%. Regarding short-term risk, HUM is more volatile compared to CVS. This indicates higher risk in terms of short-term price fluctuations for HUM.Check CVS's competition here
Elevance Health Inc. (NYSE: ANTM)
HUM vs ANTM Comparison August 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 44.8B. In comparison, ANTM has a market cap of 114.6B. Regarding current trading prices, HUM is priced at $387.09 on the NYSE, while ANTM trades at $482.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 23.52, whereas ANTM's P/E ratio is 18.99. In terms of profitability, HUM's ROE is +0.07%, compared to ANTM's ROE of +0.11%. Regarding short-term risk, HUM is more volatile compared to ANTM. This indicates higher risk in terms of short-term price fluctuations for HUM.Check ANTM's competition here
Elevance Health Inc. (NYSE: ELV)
HUM vs ELV Comparison August 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 44.8B. In comparison, ELV has a market cap of 84.7B. Regarding current trading prices, HUM is priced at $387.09 on the NYSE, while ELV trades at $395.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 23.52, whereas ELV's P/E ratio is 13.28. In terms of profitability, HUM's ROE is +0.07%, compared to ELV's ROE of +0.11%. Regarding short-term risk, HUM is more volatile compared to ELV. This indicates higher risk in terms of short-term price fluctuations for HUM.Check ELV's competition here
Cigna Corporation (NYSE: CI)
HUM vs CI Comparison August 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 44.8B. In comparison, CI has a market cap of 72.4B. Regarding current trading prices, HUM is priced at $387.09 on the NYSE, while CI trades at $276.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 23.52, whereas CI's P/E ratio is 8.86. In terms of profitability, HUM's ROE is +0.07%, compared to CI's ROE of +0.15%. Regarding short-term risk, HUM is more volatile compared to CI. This indicates higher risk in terms of short-term price fluctuations for HUM.Check CI's competition here
Centene Corp. (NYSE: CNC)
HUM vs CNC Comparison August 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 44.8B. In comparison, CNC has a market cap of 32B. Regarding current trading prices, HUM is priced at $387.09 on the NYSE, while CNC trades at $66.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 23.52, whereas CNC's P/E ratio is 25.74. In terms of profitability, HUM's ROE is +0.07%, compared to CNC's ROE of -0.24%. Regarding short-term risk, HUM is more volatile compared to CNC. This indicates higher risk in terms of short-term price fluctuations for HUM.Check CNC's competition here
Molina Healthcare, Inc. (NYSE: MOH)
HUM vs MOH Comparison August 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 44.8B. In comparison, MOH has a market cap of 10.2B. Regarding current trading prices, HUM is priced at $387.09 on the NYSE, while MOH trades at $202.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 23.52, whereas MOH's P/E ratio is 28.10. In terms of profitability, HUM's ROE is +0.07%, compared to MOH's ROE of -0.00%. Regarding short-term risk, HUM is more volatile compared to MOH. This indicates higher risk in terms of short-term price fluctuations for HUM.Check MOH's competition here
Oscar Health, Inc. (NYSE: OSCR)
HUM vs OSCR Comparison August 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 44.8B. In comparison, OSCR has a market cap of 7.2B. Regarding current trading prices, HUM is priced at $387.09 on the NYSE, while OSCR trades at $28.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 23.52, whereas OSCR's P/E ratio is 19.97. In terms of profitability, HUM's ROE is +0.07%, compared to OSCR's ROE of +0.39%. Regarding short-term risk, HUM is more volatile compared to OSCR. This indicates higher risk in terms of short-term price fluctuations for HUM.Check OSCR's competition here
Alignment Healthcare, Inc. (NASDAQ: ALHC)
HUM vs ALHC Comparison August 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 44.8B. In comparison, ALHC has a market cap of 2.7B. Regarding current trading prices, HUM is priced at $387.09 on the NYSE, while ALHC trades at $13.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 23.52, whereas ALHC's P/E ratio is 146.67. In terms of profitability, HUM's ROE is +0.07%, compared to ALHC's ROE of +0.20%. Regarding short-term risk, HUM is more volatile compared to ALHC. This indicates higher risk in terms of short-term price fluctuations for HUM.Check ALHC's competition here
Clover Health Investments, Corp. (NASDAQ: CLOV)
HUM vs CLOV Comparison August 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 44.8B. In comparison, CLOV has a market cap of 2.3B. Regarding current trading prices, HUM is priced at $387.09 on the NYSE, while CLOV trades at $4.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 23.52, whereas CLOV's P/E ratio is 102.95. In terms of profitability, HUM's ROE is +0.07%, compared to CLOV's ROE of -0.05%. Regarding short-term risk, HUM is more volatile compared to CLOV. This indicates higher risk in terms of short-term price fluctuations for HUM.Check CLOV's competition here
Bright Health Group, Inc. (NYSE: BHG)
HUM vs BHG Comparison August 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 44.8B. In comparison, BHG has a market cap of 130.5M. Regarding current trading prices, HUM is priced at $387.09 on the NYSE, while BHG trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 23.52, whereas BHG's P/E ratio is -0.12. In terms of profitability, HUM's ROE is +0.07%, compared to BHG's ROE of +0.04%. Regarding short-term risk, HUM is less volatile compared to BHG. This indicates lower risk in terms of short-term price fluctuations for HUM.Check BHG's competition here
Caring Brands, Inc. (NASDAQ: CABR)
HUM vs CABR Comparison August 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 44.8B. In comparison, CABR has a market cap of 12.9M. Regarding current trading prices, HUM is priced at $387.09 on the NYSE, while CABR trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 23.52, whereas CABR's P/E ratio is -2.54. In terms of profitability, HUM's ROE is +0.07%, compared to CABR's ROE of -3.28%. Regarding short-term risk, HUM is less volatile compared to CABR. This indicates lower risk in terms of short-term price fluctuations for HUM.Check CABR's competition here
Universal American Corporation (NYSE: UAM)
HUM vs UAM Comparison August 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 44.8B. In comparison, UAM has a market cap of 0. Regarding current trading prices, HUM is priced at $387.09 on the NYSE, while UAM trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 23.52, whereas UAM's P/E ratio is 1.01. In terms of profitability, HUM's ROE is +0.07%, compared to UAM's ROE of +0.17%. Regarding short-term risk, HUM is more volatile compared to UAM. This indicates higher risk in terms of short-term price fluctuations for HUM.Check UAM's competition here
Aetna Inc. (NYSE: AET)
HUM vs AET Comparison August 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 44.8B. In comparison, AET has a market cap of 0. Regarding current trading prices, HUM is priced at $387.09 on the NYSE, while AET trades at $106.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 23.52, whereas AET's P/E ratio is 9.57. In terms of profitability, HUM's ROE is +0.07%, compared to AET's ROE of +0.11%. Regarding short-term risk, HUM is more volatile compared to AET. This indicates higher risk in terms of short-term price fluctuations for HUM.Check AET's competition here
Magellan Health, Inc. (NASDAQ: MGLN)
HUM vs MGLN Comparison August 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 44.8B. In comparison, MGLN has a market cap of 0. Regarding current trading prices, HUM is priced at $387.09 on the NYSE, while MGLN trades at $94.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 23.52, whereas MGLN's P/E ratio is 8.49. In terms of profitability, HUM's ROE is +0.07%, compared to MGLN's ROE of +0.00%. Regarding short-term risk, HUM is more volatile compared to MGLN. This indicates higher risk in terms of short-term price fluctuations for HUM.Check MGLN's competition here
Triple-S Management Corporation (NYSE: GTS)
HUM vs GTS Comparison August 2026
Humana Inc. (NYSE: HUM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HUM stands at 44.8B. In comparison, GTS has a market cap of 0. Regarding current trading prices, HUM is priced at $387.09 on the NYSE, while GTS trades at $35.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HUM currently has a P/E ratio of 23.52, whereas GTS's P/E ratio is 10.41. In terms of profitability, HUM's ROE is +0.07%, compared to GTS's ROE of +0.07%. Regarding short-term risk, HUM is more volatile compared to GTS. This indicates higher risk in terms of short-term price fluctuations for HUM.Check GTS's competition here